OncoSec Medical Performance
| ONCSDelisted Stock | USD 0.0002 0.00 0.00% |
The company holds a Beta of -2.57, which implies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning OncoSec Medical are expected to decrease by larger amounts. On the other hand, during market turmoil, OncoSec Medical is expected to outperform it. OncoSec Medical right now holds a risk of 0.0%. Please check OncoSec Medical mean deviation, jensen alpha, as well as the relationship between the Jensen Alpha and kurtosis , to decide if OncoSec Medical will be following its historical price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days OncoSec Medical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, OncoSec Medical is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors. ...more
| Begin Period Cash Flow | 46 M | |
| Total Cashflows From Investing Activities | -244.9 K |
OncoSec |
OncoSec Medical Relative Risk vs. Return Landscape
If you would invest 0.02 in OncoSec Medical on January 25, 2024 and sell it today you would earn a total of 0.00 from holding OncoSec Medical or generate 0.0% return on investment over 90 days. OncoSec Medical is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than OncoSec, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
OncoSec Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for OncoSec Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as OncoSec Medical, and traders can use it to determine the average amount a OncoSec Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| ONCS |
Based on monthly moving average OncoSec Medical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of OncoSec Medical by adding OncoSec Medical to a well-diversified portfolio.
OncoSec Medical Fundamentals Growth
OncoSec Stock prices reflect investors' perceptions of the future prospects and financial health of OncoSec Medical, and OncoSec Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on OncoSec Stock performance.
| Return On Equity | -4.1 | |||
| Return On Asset | -0.93 | |||
| Current Valuation | 5.6 M | |||
| Shares Outstanding | 5.96 M | |||
| Price To Earning | (3.12) X | |||
| Price To Book | 0.78 X | |||
| EBITDA | (35.92 M) | |||
| Cash And Equivalents | 19.48 M | |||
| Cash Per Share | 0.50 X | |||
| Total Debt | 6.17 M | |||
| Debt To Equity | 0.76 % | |||
| Book Value Per Share | (1.85) X | |||
| Cash Flow From Operations | (32.14 M) | |||
| Earnings Per Share | (20.31) X | |||
| Total Asset | 21.88 M | |||
| Retained Earnings | (285.96 M) | |||
| Current Asset | 29.42 M | |||
| Current Liabilities | 3.47 M | |||
About OncoSec Medical Performance
To evaluate OncoSec Medical Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when OncoSec Medical generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare OncoSec Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand OncoSec Medical market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents OncoSec's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.OncoSec Medical Incorporated, a late-stage immuno-oncology company, focuses on designing, developing, commercializing intra-tumoral DNA-based therapeutics to stimulate and augment anti-tumor immune responses for the treatment of cancer. The company was incorporated in 2008 and is headquartered in Pennington, New Jersey. Oncosec Medical operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 54 people.Things to note about OncoSec Medical performance evaluation
Checking the ongoing alerts about OncoSec Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for OncoSec Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| OncoSec Medical is not yet fully synchronised with the market data | |
| OncoSec Medical has some characteristics of a very speculative penny stock | |
| OncoSec Medical has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (34.18 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| OncoSec Medical currently holds about 19.48 M in cash with (32.14 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.5, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 28.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing OncoSec Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether OncoSec Medical's stock is overvalued or undervalued compared to its peers.
- Examining OncoSec Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating OncoSec Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of OncoSec Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of OncoSec Medical's stock. These opinions can provide insight into OncoSec Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the OncoSec Medical information on this page should be used as a complementary analysis to other OncoSec Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Consideration for investing in OncoSec Stock
If you are still planning to invest in OncoSec Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the OncoSec Medical's history and understand the potential risks before investing.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |